GlassScriptPhysician profile
Jason Capra
NPI 1144431321
$18,932.58
in general payments reported to CMS, 2019-2025
18 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $106 · 2021: $325 · 2022: $119 · 2023: $37.02 · 2024: $610 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483 · Travel and Lodging: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,482.73 |
| Travel and Lodging | $184.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Richard Wolf Medical Instruments Corp. | $16,559.77 | 2019 | |
| Globus Medical, INC. | $952.61 | 2025 | Senza, Vyrsa V1, Vyrsa V1 |
| Nevro Corp. | $608.39 | 2019-2024 | Senza |
| Si-Bone, INC. | $146.15 | 2021-2025 | |
| Abbott Laboratories | $133.26 | 2020-2024 | Eterna |
| Boston Scientific Corporation | $124.45 | 2021-2025 | Intracept |
| Medtronic, INC. | $113.39 | 2022 | |
| Stimwave Technologies Incorporated | $108.79 | 2019 | |
| Medtronic USA, INC. | $30.06 | 2020 | |
| Pacira Therapeutics, INC. | $26.03 | 2021 | |
| Abbvie INC. | $24.61 | 2023 | Botox, Ubrelvy |
| Nalu Medical, INC. | $21.56 | 2025 | Nalu Neurostimulation System |
| Merck Sharp & Dohme LLC | $18.71 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.46 | 2021 | |
| Avanos Medical | $16.14 | 2024 | Generator |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $13.37 | 2024 | Axonics |
| Mml US, INC. | $12.41 | 2023 | Reactiv8 |
| Relievant Medsystems, INC. | $5.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Capra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.